Am J Cardiol

1. KIYOHARA Y, Sakai T, Freeman LM, Katzianer D, et al
   Pulmonary Arterial Hypertension-Targeted Therapy for Pulmonary Hypertension Associated with Left Heart Disease: Bayesian and Frequentist Meta-Analysis of Randomized Controlled Trials.
   Am J Cardiol. 2026 Aug 4:S0002-9149(26)00476.
   

   >> Share

   
   

   
   Am J Hypertens

2. TOMITANI N, Hoshide S, Kario K
   Association of nocturnal hypertension, non-dipping, and exaggerated morning surge with home blood pressure monitoring: The HI-JAMP Study.
   Am J Hypertens. 2026 Aug 8:hpag099. doi: 10.1093.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

3. CHEN M, Zong F, Zhang J, Wang Y, et al
   Hsa-miR-498-5p serves as a diagnostic biomarker and regulates endothelial dysfunction via PTEN/AKT pathway in gestational hypertension.
   Biochem Biophys Res Commun. 2026;832:154386.
   

   >> Share

   
   

   
   Clin Cardiol

4. ZHANG Z, Cai D, Xu S
   Comment on "The Association of Hypertension Based on Systolic and Diastolic Blood Pressure With Dental Visits in the Population Aged 45 and Older: Cross-Section Study Results From the China Health and Retirement Longitudinal Study".
   Clin Cardiol. 2026;49:e70442.
   

   >> Share

   
   

   
   Clin Exp Hypertens

5. SHI Y, Gao P, Lin X, Zhang M, et al
   Inter-ankle systolic blood pressure difference is associated with microalbuminuria in non-diabetic hypertension patients: A cross-sectional study from two cohorts.
   Clin Exp Hypertens. 2026;48:2712543.
   

   >> Share

   
   

   
   Eur Heart J

6. KROST KM, Eichner G, Fasshauer M, Eise NJ, et al
   Markers of ultra-processed food and incident arterial hypertension in the UK Biobank.
   Eur Heart J. 2026 Aug 3:ehag614. doi: 10.1093.
   

   >> Share

   
   
7. VAURA F, Krebs K, Kiiskinen T, Ramo J, et al
   Side effects in hypertension treatment: a pharmacogenomic analysis.
   Eur Heart J. 2026 Aug 3:ehag575. doi: 10.1093.
   

   >> Share

   
   

   
   Hypertension

8. WANG X, Li XT, Chen HN, Zou HL, et al
   Chemogenetic Ca(2+) Channel Mitigates Aortic Dissection and Antihypertensive Risk.
   Hypertension. 2026 Aug 3. doi: 10.1161/HYPERTENSIONAHA.126.27008.
   

   >> Share

   
   

   
   J Am Coll Cardiol

9. GONG J, Chiu N, Clinch KA, Qian Y, et al
   Treatment of Cardiometabolic Risk Factors Among U.S. Adults With Cardiovascular-Kidney-Metabolic Syndrome.
   J Am Coll Cardiol. 2026 Jun 17:S0735-1097(26)06350.
   

   >> Share

   
   

   
   J Am Soc Nephrol

10. LEE HH, Cho SMJ, McCarthy CP, Yoo TH, et al
    Real-World Adoption of the 2021 KDIGO BP Guideline in CKD.
    J Am Soc Nephrol. 2026;37:1764-1772.
    

    >> Share

    
    
11. MALHA L, August P
    Hypertension Management in Pregnancy and Postpartum.
    J Am Soc Nephrol. 2026 Aug 3. doi: 10.1681/ASN.0000001236.
    

    >> Share

    
    

    
    J Hum Hypertens

12. LOH HH, Tay SP, Koa AJ, Yong MC, et al
    Prevalence and clinical correlates of positive aldosterone-to-renin ratio screening in obese hypertensive patients with obstructive sleep apnea: a Southeast Asian cross-sectional study.
    J Hum Hypertens. 2026 Aug 8. doi: 10.1038/s41371-026-01195.
    

    >> Share

    
    
13. GALLAGHER BD
    Why wait? the case for up-front single-pill combination therapy in stage 1 hypertension.
    J Hum Hypertens. 2026 Aug 7. doi: 10.1038/s41371-026-01197.
    

    >> Share

    
    
14. KORACEVIC G, Stojanovic M
    Intravenous or peroral antihypertensive for patients with chest discomfort and very high blood pressure?
    J Hum Hypertens. 2026 Aug 3. doi: 10.1038/s41371-026-01193.
    

    >> Share

    
    
15. KHAN A, Idrees M, Sharif M, Irshad K, et al
    "Efficacy and safety of low-dose combination (Quad pill and Triple pill) therapy versus standard of care and placebo in controlling hypertension: an updated systematic review and meta-analysis of randomized trials".
    J Hum Hypertens. 2026 Aug 1. doi: 10.1038/s41371-026-01190.
    

    >> Share

    
    

    
    J Hypertens

16. SHANTSILA E, Shantsila A, Sperrin M, Gao Z, et al
    Higher skeletal muscle mass is associated with higher blood pressure and left ventricular mass.
    J Hypertens. 2026;44:1594-1604.
    

    >> Share

    
    
17. ALYAS JT, Nielsen SF, Buus NH
    Explaining blood pressure reduction heterogeneity in sodium-glucose cotransporter-2 inhibitor trials: a meta-analysis stratified by patient characteristics.
    J Hypertens. 2026;44:1487-1498.
    

    >> Share

    
    
18. ZHANG DY, An DW, Yu YL, Kaleta BP, et al
    Home blood pressure telemonitoring reveals race-specific patterns of target organ damage.
    J Hypertens. 2026;44:1636-1646.
    

    >> Share

    
    
19. RAM CVS
    Artificial intelligence and hypertension management: experience the journey but fasten your seatbelt.
    J Hypertens. 2026;44:1499-1501.
    

    >> Share

    
    
20. CAYUELA A, Cayuela L
    Methodological inconsistencies and nomenclature errors in 'Arterial hypertension-attributable mortality in Europe', 2012-2021.
    J Hypertens. 2026;44:1659-1660.
    

    >> Share

    
    
21. ZUIN M
    Response to the letter: "methodological inconsistencies and nomenclature errors in 'arterial hypertension-attributable mortality in Europe, 2012-2021"'.
    J Hypertens. 2026;44:1660-1662.
    

    >> Share

    
    
22. YETKIN E, Atmaca H, Gurbuz DC, Yalta K, et al
    Gray zone of hypertension thresholds values can be overcome by individualized symptom-oriented approaches.
    J Hypertens. 2026;44:1664-1665.
    

    >> Share

    
    
23. ZHANG MJ, Bo YC, Shi JZ, Xu MD, et al
    The association of cardiovascular health with new-onset pulmonary hypertension and the mediating role of proteomic signatures.
    J Hypertens. 2026 Jul 28. doi: 10.1097/HJH.0000000000004409.
    

    >> Share

    
    
24. DOKU A, Kruger R, Asamoah KT, Akumiah FK, et al
    2026 ISH guidelines for the management of hypertension in Africa: the International Society of Hypertension (ISH) African Regional Advisory Group and the Pan African Society of Cardiology (PASCAR).
    J Hypertens. 2026 Jul 28. doi: 10.1097/HJH.0000000000004411.
    

    >> Share

    
    
25. GHERBESI E, Faggiano A, Sala C, Carugo S, et al
    Left ventricular hypertrophy in hypertension: a systematic review and meta-analysis of echocardiographic studies published from 2011 to 2025.
    J Hypertens. 2026 Jul 28. doi: 10.1097/HJH.0000000000004408.
    

    >> Share

    
    
26. CHEN K, Liang Y, Yin T, Lv Y, et al
    Effects of exercise on aerobic capacity in people with prehypertension or hypertension: a systematic review and meta-analysis of randomized controlled trials.
    J Hypertens. 2026 Jul 28. doi: 10.1097/HJH.0000000000004405.
    

    >> Share

    
    
27. GROBMAN B, Wang FM, Ngige AA, Rajesh S, et al
    Hypertension treatment and risk of cardiovascular disease or mortality across risk equations: results from SPRINT.
    J Hypertens. 2026 Jul 23. doi: 10.1097/HJH.0000000000004397.
    

    >> Share

    
    

    
    Lancet

28. BALASUBRAMANIAN A, Mathai SC
    Ralinepag in pulmonary arterial hypertension: a step forward.
    Lancet. 2026;408:492-493.
    

    >> Share

    
    

    
    PLoS Med

29. APOSTOLOU A, Simfukwe R, Saint A, Mushani B, et al
    Adherence to medications, lifestyle advice, and self-monitoring for type 2 diabetes and hypertension in sub-Saharan Africa: A systematic review, meta-analysis, and interactive network analysis.
    PLoS Med. 2026;23:e1005189.
    

    >> Share

    
    

    
    PLoS One

30. SIDDIQ S, Adra S, Samara KA, Aldaher B, et al
    Young-onset stroke in the UAE: A single-centre retrospective analysis of risk factors and outcomes.
    PLoS One. 2026;21:e0355300.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share